WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005014035) USE OF GALACTOSE OXIDASE FOR SELECTIVE CHEMICAL CONJUGATION OF PROTRACTOR MOLECULES TO PROTEINS OF THERAPEUTIC INTEREST
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/014035    International Application No.:    PCT/DK2004/000530
Publication Date: 17.02.2005 International Filing Date: 09.08.2004
IPC:
A61K 38/44 (2006.01)
Applicants: NOVO NORDISK HEALTH CARE AG [CH/CH]; Andreasstrasse 15, CH-8050 Zurich (CH) (For All Designated States Except US).
BEHRENS, Carsten [DK/DK]; (DK) (For US Only).
GARIBAY, Patrick, William [US/DK]; (DK) (For US Only).
ZUNDEL, Magali [FR/DK]; (DK) (For US Only).
KLAUSEN, Niels, Kristian [DK/DK]; (DK) (For US Only).
BJØRN, Søren, E. [DK/DK]; (DK) (For US Only)
Inventors: BEHRENS, Carsten; (DK).
GARIBAY, Patrick, William; (DK).
ZUNDEL, Magali; (DK).
KLAUSEN, Niels, Kristian; (DK).
BJØRN, Søren, E.; (DK)
Common
Representative:
NOVO NORDISK A/S; Corporate Patents, Novo Allé, DK-2880 Bagsværd (DK)
Priority Data:
PA 2003 01145 08.08.2003 DK
60/494,447 12.08.2003 US
PA 2003 01646 05.11.2003 DK
60/519,212 12.11.2003 US
Title (EN) USE OF GALACTOSE OXIDASE FOR SELECTIVE CHEMICAL CONJUGATION OF PROTRACTOR MOLECULES TO PROTEINS OF THERAPEUTIC INTEREST
(FR) UTILISATION DE GALACTOSE OXYDASE POUR LA CONJUGAISON CHIMIQUE SELECTIVE DE MOLECULES D'EXTRACTION A DES PROTEINES D'INTERET THERAPEUTIQUE
Abstract: front page image
(EN)This invention relates to novel compounds, methods for selective chemical conjugation of protractor molecules and the use thereof for diagnostic and/or therapeutic purposes.
(FR)Cette invention concerne de nouveaux composés, des procédés de conjugaison chimique sélective de molécules d'extraction et leur utilisation à des fins diagnostiques et/ou thérapeutiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)